Sinotherapeutics Inc. A (688247) — Cash Flow Quality Index
Sinotherapeutics Inc. A (688247) has a Cash Flow Quality Index of 2.01x as of December 2025. Operating cash flow of CN¥95.33 Million exceeds net income of CN¥47.48 Million, indicating high earnings quality where cash backs reported profits. Also explore Sinotherapeutics Inc. A total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sinotherapeutics Inc. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Sinotherapeutics Inc. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688247 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Sinotherapeutics Inc. A (2020–2025)
Year-by-year earnings quality comparison for Sinotherapeutics Inc. A. For live market cap and the full company financial profile, see Sinotherapeutics Inc. A market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.01x | CN¥95.33 Million | CN¥47.48 Million | ▲ +96.9% |
| 2024 | 1.02x | CN¥130.23 Million | CN¥127.70 Million | ▲ +380.7% |
| 2023 | 0.21x | CN¥12.96 Million | CN¥61.07 Million | ▼ -73.1% |
| 2022 | 0.79x | CN¥73.18 Million | CN¥92.94 Million | ▼ -27.1% |
| 2021 | 1.08x | CN¥145.77 Million | CN¥134.92 Million | ▼ -40.0% |
| 2020 | 1.80x | CN¥210.04 Million | CN¥116.54 Million | — |